Screen your IVF embryos for chromosomal abnormalities before transfer. Select only chromosomally normal embryos to maximise your chance of a successful, healthy pregnancy.
Transferring a chromosomally normal embryo significantly increases the chance of a successful pregnancy per transfer.
Most early miscarriages are caused by chromosomal abnormalities. PGT-A reduces this risk substantially.
Confidence in the selected embryo enables single embryo transfer, reducing twin pregnancy risks.
Fewer failed implantations and repeat IVF cycles, saving time, cost, and emotional burden.
Embryo Development
After egg retrieval and fertilisation via IVF or ICSI, embryos are cultured to the blastocyst stage (day 5–6).
Embryo Biopsy
3–5 cells are removed from the trophectoderm (the outer layer of the blastocyst that becomes the placenta) by a skilled embryologist.
Vitrification
All biopsied embryos are cryopreserved (frozen) while the biopsy samples are sent for analysis.
Genetic Analysis
The laboratory analyses all 23 pairs of chromosomes using NGS (Next Generation Sequencing). Results take 5–14 days.
Frozen Embryo Transfer
Only chromosomally normal (euploid) embryos are thawed and transferred in a subsequent cycle.
Our fertility specialists will help you decide if PGT-A is right for your situation.